Intelligent Bio Solutions Inc.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · New York, NY
INBS chart
What traders are saying about $INBS
Latest postsIntelligent Bio Solutions Inc. news
- Intelligent Bio Solutions Inc. Estimates – NASDAQ:INBS
TradingView ·
- CEO pay totaled $661K in fiscal 2026, Intelligent Bio Solutions (INBS) annual report amendment shows.
Stock Titan ·
- Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
Yahoo Finance ·
- Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Yahoo Finance ·
- Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
Yahoo Finance ·
- Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
Yahoo Finance ·
- Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
Yahoo Finance ·
- Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
Yahoo Finance ·
- Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
Yahoo Finance ·
- Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
Yahoo Finance ·
- Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
Yahoo Finance ·
- Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System
Yahoo Finance ·
Intelligent Bio Solutions Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $4.2M | $3.1M | $3.1M | $1.3M |
| Net income | -$12.5M | -$10.6M | -$10.2M | -$10.6M |
| Diluted EPS | $-8.44 | $-20.04 | $-6.38 | $-127.00 |
| Total assets (year end) | – | $17.7M | $8.7M | $8.8M |
| Cash and equivalents (year end) | – | $740,371 | $2.2M | $1.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Intelligent Bio Solutions Inc.
- Ticker
- INBS (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1725430
- Former names
- GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
Frequently asked questions
What exchange is Intelligent Bio Solutions Inc. listed on?
Intelligent Bio Solutions Inc. trades on the Nasdaq under the ticker symbol INBS.
What industry is Intelligent Bio Solutions Inc. in?
Intelligent Bio Solutions Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Intelligent Bio Solutions Inc. headquartered?
Intelligent Bio Solutions Inc.'s business address on file with the SEC is in New York, NY.
When does Intelligent Bio Solutions Inc.'s fiscal year end?
Intelligent Bio Solutions Inc.'s fiscal year ends on June 30.
How much revenue did Intelligent Bio Solutions Inc. report?
Intelligent Bio Solutions Inc. reported $4.2M in revenue for calendar year 2026, according to its SEC filings.